Tag: Tata CRISPR

DCGI approves commercial launch of low cost Covid-19 test ‘Feluda’

New Delhi: The Drugs Controller General of India has approved the commercial launch of ‘Feluda‘, the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19...